Literature DB >> 17699449

Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.

Nelson Leung1, Angela Dispenzieri, Martha Q Lacy, Shaji K Kumar, Suzanne R Hayman, Fernando C Fervenza, Stephen S Cha, Morie A Gertz.   

Abstract

Ig light chain-associated amyloidosis is a fatal plasma cell proliferative disorder that is characterized by fibril deposition in various organs. High-dose melphalan followed by autologous stem cell transplantation has been shown to improve organ dysfunction and survival. This study was undertaken to investigate factors that influence renal response. Patients who had AL amyloidosis with > or =1 g/d proteinuria and a minimum follow-up of 12 mo were recruited. Renal response was defined by >50% reduction in proteinuria with <25% decline in renal function. Hematologic response was defined as a 50% reduction in serum monoclonal protein or free light chains. Baseline characteristics were examined for relationship to renal response. Thirteen of the 135 patients were excluded for various reasons. Median follow-up was 45.4 mo. Hematologic and renal response was noted in 73 and 43.4% of the patients, respectively. Median response time for the kidney was 10 mo (1 to 40 mo). In univariate analysis, low cardiac troponin T (cTnT), higher albumin, lower proteinuria, and hematologic response were associated with renal response. In multivariate analysis, cTnT and proteinuria were predictive of renal response. Renal response was associated with a longer survival than hematologic response alone. This study showed that severe proteinuria and high cTnT negatively affected renal response after autologous stem cell transplantation. Achievement of renal response was associated with improved survival. These results suggest that early intervention with aggressive therapy is not only justified but recommended to achieve optimal response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699449     DOI: 10.2215/CJN.02450706

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  9 in total

1.  Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.

Authors:  Christopher P Venner; Julian D Gillmore; Sajitha Sachchithanantham; Shameem Mahmood; Thirusha Lane; Darren Foard; Murielle Roussel; Lisa Rannigan; Simon Dj Gibbs; Jennifer H Pinney; Carol J Whelan; Helen J Lachmann; Philip N Hawkins; Ashutosh D Wechalekar
Journal:  Haematologica       Date:  2014-09-05       Impact factor: 9.941

2.  Urinary albumin excretion patterns of patients with cast nephropathy and other monoclonal gammopathy-related kidney diseases.

Authors:  Nelson Leung; Morie Gertz; Robert A Kyle; Fernando C Fervenza; Maria V Irazabal; Alfonso Eirin; Shaji Kumar; Stephen S Cha; S Vincent Rajkumar; Martha Q Lacy; Steve R Zeldenrust; Francis K Buadi; Suzanne R Hayman; Samih H Nasr; Sanjeev Sethi; Marina Ramirez-Alvarado; Thomas E Witzig; Sandra M Herrmann; Angela Dispenzieri
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-27       Impact factor: 8.237

Review 3.  Treatment of immunoglobulin light chain amyloidosis.

Authors:  Morie A Gertz; Steven R Zeldenrust
Journal:  Curr Hematol Malig Rep       Date:  2009-04       Impact factor: 3.952

4.  Clinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myeloma.

Authors:  Sumit Madan; Angela Dispenzieri; Martha Q Lacy; Francis Buadi; Suzanne R Hayman; Steven R Zeldenrust; S Vincent Rajkumar; Morie A Gertz; Shaji K Kumar
Journal:  Mayo Clin Proc       Date:  2010-03       Impact factor: 7.616

Review 5.  Amyloid nephropathy.

Authors:  Mazdak A Khalighi; W Dean Wallace; Miguel F Palma-Diaz
Journal:  Clin Kidney J       Date:  2014-03-13

6.  Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma.

Authors:  R Khan; S Apewokin; M Grazziutti; S Yaccoby; J Epstein; F van Rhee; A Rosenthal; S Waheed; S Usmani; S Atrash; S Kumar; A Hoering; J Crowley; J D Shaughnessy; B Barlogie
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

7.  Renal ablation using bilateral ureteral ligation for nephrotic syndrome due to renal amyloidosis.

Authors:  Mira T Keddis; Mark D Stegall; Stephen C Textor
Journal:  Clin Kidney J       Date:  2012-02-22

8.  Estimation of Daily Proteinuria in Patients with Amyloidosis by Using the Protein-To-Creatinine ratio in Random Urine Samples.

Authors:  Giampaolo Talamo; A Mir Muhammad; Manoj K Pandey; Junjia Zhu; Michael H Creer; Jozef Malysz
Journal:  Rare Tumors       Date:  2015-02-18

9.  Oligosecretory Myeloma With Amyloidosis and Alopecia.

Authors:  Anum Bilal; Paul Der Mesropian; Franklin Lam; Gulvahid Shaikh
Journal:  J Investig Med High Impact Case Rep       Date:  2018-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.